Results 131 to 140 of about 50,945 (202)

Postinfluenza A(H3N2) refractory invasive pulmonary aspergillosis

Journal of the Formosan Medical Association, 2017
Ku, Yee-Huang, Chuang, Yin-Ching, Yu, Wen-Liang   +2 more
openaire   +3 more sources

Severity of Clinical Presentation and Outcomes in Hospitalized Adult People With Influenza by Type and Subtype, United States-2017-2020. [PDF]

Clin Infect Dis
Cleary S, Lewis NM, Talbot HK, Zhu Y, Martin ET, Monto AS, Gaglani M, Murthy K, Zimmerman RK, Silveira FP, Tenforde MW, Patel MM, Ellington S, Olson SM.   +13 more
europepmc   +1 more source

Fatal human H3N8 influenza virus has a moderate pandemic risk. [PDF]

PLoS Pathog
Le Sage V, Vu MN, Maltepes MA, Wang S, Snow BA, Merrbach GA, Benton AJ, Zirckel KE, Petnuch SE, Marble CN, Rigatti LH, Paulson JC, Drapeau EM, McElroy AK, Hensley SE, Moncla LH, Lakdawala SS.   +16 more
europepmc   +1 more source

Accumulation of Quinolinic Acid Modulates the Pulmonary Immune Response During Influenza Infection. [PDF]

Int J Tryptophan Res
Pamart G, Hennart B, Ollivier A, Kervoaze G, Pichavant M, Gosset P, Le Rouzic O, Poulain-Godefroy O.   +7 more
europepmc   +1 more source

Evolutionary patterns of pH1N1 and H3N2 in relation to vaccine use. [PDF]

BMC Genomics
Lin YW, Guo LZ, Tsai YT, Chu YC, Lin YF, Takemura K, Huang CH, Chang HH, Lee CS.   +8 more
europepmc   +1 more source

Reduced neutralising antibody responses against emerging 2025/26 influenza A(H1N1)pdm09 subclade D.3.1 and A(H3N2) subclade K viruses among healthcare workers, Finland, August to October 2025. [PDF]

Euro Surveill
Ikonen N, Haveri A, Lindh E, Liedes O, Vara S, Pakkanen SH, Kantele A, Nieminen T, Anttila VJ, Välimaa H, Melin M, Savolainen-Kopra C, Nohynek H.   +12 more
europepmc   +1 more source

Is the emerging influenza A(H3N2) K subclade a specific threat for older adults? [PDF]

Geroscience
Quarleri J, Delpino MV.
europepmc   +1 more source

Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026. [PDF]

Euro Surveill
Separovic L, Sabaiduc S, Zhan Y, Kaweski SE, Olsha R, Hasso M, Mather RG, Carazo S, Lacroix C, Meunier I, Salhi LN, Dickinson JA, Zelyas N, Jassem AN, Dover K, Ranadheera C, Gao R, Bastien N, Skowronski DM.   +18 more
europepmc   +1 more source

Epidemiological diversity of seasonal influenza and post-COVID-19 pandemic changes in the UK, 2015-2025: a surveillance-based analysis. [PDF]

BMC Public Health
Yuan L, Sun C, Wang H, Zeng Z.
europepmc   +1 more source

Emergence of influenza A(H3N2) subclade K in northeast Ohio in autumn 2025. [PDF]

J Clin Microbiol
Xu X, Hull W, Plunkett D, Tu ZJ, Ross TM, Rhoads DD, Wang H.   +6 more
europepmc   +1 more source